Xponance, Inc. Cerus Corp Transaction History
Xponance, Inc.
- $10.7 Billion
- Q4 2024
A detailed history of Xponance, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Xponance, Inc. holds 14,229 shares of CERS stock, worth $25,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,229
Previous 11,234
26.66%
Holding current value
$25,612
Previous $19,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CERS
# of Institutions
162Shares Held
144MCall Options Held
84.2KPut Options Held
55.5K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.8MShares$37.5 Million0.28% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$35.1 Million0.36% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$18.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$15 Million0.06% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $319M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...